Overview
CJC-1295 (without DAC / Mod GRF 1-29) combined with Ipamorelin is a synergistic dual-peptide formulation engineered to maximize growth hormone secretagogue activity. By pairing a short-acting growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue receptor (GHSR) agonist, this blend targets distinct pituitary pathways simultaneously. This dual-action mechanism allows researchers to evaluate amplified signaling designed for triggering the body to naturally release Growth Hormone in powerful bursts while preserving normal endocrine feedback loops.
Disclaimer: This product is for research purposes only. It is not intended for direct human consumption.






Reviews
There are no reviews yet.